Summary
Overview
Work History
Education
Skills
Certification
Timeline
Generic

Vanessa Inglis

Phoenixville

Summary

Dynamic finance professional recognized as a trusted business partner with a strong emphasis on cross-collaboration and data analytical capabilities. Exceptional ability to analyze complex data sets and translate insights into actionable strategies, facilitating informed decision-making across departments. Experienced in working closely with diverse teams to align financial strategies with organizational goals, fostering strong relationships to drive success. Committed to building consensus and leveraging financial and operational insights from various stakeholders to enhance effectiveness and support strategic initiatives.

Overview

6
6
years of professional experience
1
1
Certification

Work History

Senior Financial Analyst - Pricing Strategy

Johnson & Johnson
08.2023 - Current
  • Spearheaded launch initiatives for three oncology assets (LAZCLUZE, RYBREVANT FASPRO, TAR-200), driving leadership reviews for various GPO contracting and pricing strategies.
  • Led groundbreaking LRFP financial analyses that prepared the ERLEADA brand for critical macro events (2025 Part D Redesign, Xtandi LOE, IRA Negotiation), informing key strategic adjustments.
  • Directed the Erleada Payer Contracting Profitability Assessment, delivering financial sensitivity analyses that educated leadership (up to VAP and Brand President) on 2026 Part D & Commercial bid strategies, achieving RFP bid rates that were ~$65MM favorable to LRFP assumptions and encouraged long-term GTN preservation.
  • Revamped tier-based volume performance rebates across multiple ERLEADA GPO contracts, resulting in competitive offers that aligned to overall brand strategy and increased contract negotiation effectiveness. Provided end-to-end financial support for compliant CPC approval with all new contracts and extensions.

Senior Financial Analyst - Worldwide FP&A, MedTech

Johnson & Johnson
01.2022 - 08.2023
  • Led annual Enterprise Value Creation (VC) projects for 2022 and 2023, collaborating with cross-functional Finance teams to identify key financial metrics and develop strategic narratives that support business growth initiatives and enhance operational efficiency.
  • Managed a $70 million MT Group Operating Company budget, partnering effectively with Group Finance and leadership teams to build automated reports, enabling accurate forecasts and thorough risk assessments within a matrixed organizational structure.
  • Provided subject matter expertise within Vision SigniFi and Data Science workstreams, facilitating data-driven decision-making and supporting project initiatives related to predictive analytics and performance visualizations.
  • Executed comprehensive financial reporting for Worldwide MedTech (MT), providing strategic insights to the MT Group CFO and Executive Committee for effective business evaluation and planning.

FLDP Financial Analyst - US BWI Commercial

Johnson & Johnson
01.2021 - 01.2022
  • Led efficiency analytics for Clinical Account Specialists (CAS), utilizing Qlik for big data visualization to analyze the performance of over 1,000 CAS. Collaborated with VPs within the sales organization and cross-functional teams to develop data-driven insights that optimized future hiring decisions, resulting in significant operational cost savings and improved case efficiency metrics.
  • Developed and implemented the first worldwide Tech Services (TS) Profit and Loss framework, leading to the identification and realization of $8MM in global savings. Collaborated closely with the PIC Center of Excellence, TS, and regional finance teams to create sustainable processes that reinforced long-term operational efficiency.
  • Revamped financial reporting processes for BWI and Acclarent TS, increasing transparency and accountability. This strategic transformation led to more efficient finance-led planning cycles, enabling robust strategic analytics for several New Product Introductions.

FLDP Financial Analyst - Global Deliver Supply Chain

Johnson & Johnson
06.2019 - 01.2021
  • Spearheaded Global Consolidations and FP&A for the Vision Deliver organization, driving financial results (NCC, % NTS, CIPs) by effectively communicating with the regional teams and providing visibility to risks and opportunities.
  • Led the consolidation and comprehensive analysis of the Deliver hosting model and capital projects related to MD/DC Mooresville and Order-to-Cash, enhancing forecasting accuracy and facilitating timely quarter closes.
  • Provided direct financial support to Global MedTech & Facilities organizations, delivering budget planning and ad-hoc financial analysis, while fostering effective partnerships to align financial goals with business objectives.

Education

Bachelor of Science - Accounting, Marketing

Lehigh University
Bethlehem, PA
05.2019

Skills

  • Cross-Functional Collaboration
  • Data Analysis Expertise
  • Workflow Optimization
  • Analytical Strategic Planning
  • Executive Presence
  • Pharmaceutical Industry Experience

Certification

Certified Management Accountant (CMA), Institute of Management Accountants, 07/22

Timeline

Senior Financial Analyst - Pricing Strategy

Johnson & Johnson
08.2023 - Current

Senior Financial Analyst - Worldwide FP&A, MedTech

Johnson & Johnson
01.2022 - 08.2023

FLDP Financial Analyst - US BWI Commercial

Johnson & Johnson
01.2021 - 01.2022

FLDP Financial Analyst - Global Deliver Supply Chain

Johnson & Johnson
06.2019 - 01.2021

Bachelor of Science - Accounting, Marketing

Lehigh University

Similar Profiles

CREATE PROFILE
Vanessa Inglis